-
-
-
-
-
-
-
BofA Securities stays Underperform on ProKidney Corp. (PROK) after earnings on trial risk
-
-
-
-
-
-
-
ProKidney secures FDA alignment on accelerated approval pathway for rilparencel
-
-
-
-
-
-
-
ProKidney Corp. (PROK) Misses Q3 EPS by 1c
-
-
-
-
-
-
-
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
-
-
-
-
-
-
-
ProKidney Reports Third Quarter Financial Results
-
-
-
-
-
-
-
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
-
-
-
-
-
-
-
ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights
-
1,217,554 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

